The panel has also changed the recommendation for the MMRV vaccine and delayed a vote on the hepatitis B jab.

The CDC's vaccine advisory panel is scheduled to meet Thursday and Friday to discuss the long-used hepatitis B vaccine for newborns and other vaccines.

The hepatitis B vaccine has been recommended for all infants and young children since 1991.

Members of a federal vaccine advisory panel voted to end its recommendation for individuals to obtain a COVID-19 vaccination in favor of personal assessment.

The panel has also changed the recommendation for the MMRV vaccine and delayed a vote on the hepatitis B jab.